Navigation Links
Micromet, Inc. To Regain Rights to Blinatumomab in North America; Reports Financial Results for the Fourth Quarter and Full Year ended December 31, 2008
Date:3/12/2009

2008 2007 Assets Current assets: Cash and cash equivalents $46,168 $27,066 Accounts receivable 3,424 4,689 Prepaid expenses and other current assets 1,950 2,579 Total current assets 51,542 34,334 Property and equipment, net 3,322 4,390 Goodwill 6,462 6,462 Patents, net 5,250 7,680 Deposits and other assets 959 196 Restricted cash 3,140 3,190 Total assets $70,675 $56,252 Liabilities and Stockholders' Equity Current liabilities: Accounts payable $710 $2,335 Accrued expenses 6,492 5,285 Warrant liabilities 12,294 5,218 Current portion of long-term debt obligations - 2,401 Current portion of deferred revenue 4,054 3,360 Total current liabilities 23,550 18,599 Deferred revenue, net of current portion 7,555 8,366 Other non-current liabilities 2,025 2,055 Long-term debt obligations, net of current portion 2,157 2,254 Commitments Stockholders' equity: Preferred stock, $0.00004 par value; 10,000 shares authorized; no shares issued and outstanding - - Common stock, $0.00004 par value; 150,000 shares authorized; 50,913 and 40,778 sha
'/>"/>
SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Micromet, Inc. Reports Third Quarter 2008 Financial Results
2. Micromet, Inc. to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results
3. Micromet, Inc. Fills Audit Committee Vacancy and Regains Compliance With NASDAQ Marketplace Rule
4. Micromet, Inc. Appoints Barclay Phillips as Senior Vice President and Chief Financial Officer
5. Micromet, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
6. Micromet, Inc. to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results
7. Micromet, Inc. Elects Joseph P. Slattery to Board of Directors
8. Micromet, Inc. to Present at the Sal. Oppenheim 2nd European Healthcare Conference
9. Verenium Regains Compliance With Nasdaq Continued Listing Requirement
10. Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQs Minimum Bid Price Rule
11. Peregrine Pharmaceuticals Receives Letter from NASDAQ Citing Failure to Regain Compliance with Minimum Bid Price Rule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ... August 04, 2015 , ... RPS Diagnostics ... – today announced that Robert A. Gregg, PhD, has joined RPS as Senior ... years of relevant experience and remarkable achievements in the medical device and diagnostics ...
(Date:8/4/2015)... ... August 04, 2015 , ... On August 4, 2015, ... diverse selection of entrepreneurs from across the United States to talk about their experiences ... honored to be chosen to be among the attendees. , One of the day’s ...
(Date:8/3/2015)... , Aug. 3, 2015  ArroGen Group, an ... new Fingerprint Molecular Identification™ (FMID) technology Aug. 2-8 ... in Sacramento, Calif. ... will enable law enforcement agents, district attorneys and ... criminal suspects. By analyzing chemical residues ...
(Date:8/3/2015)... , Aug. 3, 2015  Merck KGaA, Darmstadt, ... innovative and top-quality high-tech products in the healthcare, life ... the US-based company Nano-C, their development and launch of ... organic photovoltaics (OPV). Merck KGaA, Darmstadt, Germany ... the growing OPV sector. Novel derivatives: highly ...
Breaking Biology Technology:RPS Diagnostics Welcomes Robert Gregg as Senior Vice President of Clinical and Regulatory Affairs 2RPS Diagnostics Welcomes Robert Gregg as Senior Vice President of Clinical and Regulatory Affairs 3White House Invites uBiome CEO Jessica Richman to First-Ever Startup Demo Day 2ArroGen Previews New Fingerprint Molecular Identification Technology 2Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 2Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 3Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 4
... and RESEARCH TRIANGLE PARK, N.C., June 8 CSL Limited ... have mutually agreed to terminate their merger agreement, announced on ... for US$3.1 billion in cash. , , Dr. Brian ... are disappointed that the U.S. Federal Trade Commission (FTC) resolved ...
... , , INCLINE VILLAGE, Nev., June 8 ... announced revenue guidance for the second quarter ended June 30, ... for the second quarter of 2008. The increase is due ... Avastin(R), and Lucentis(R), which are marketed by Genentech, and sales ...
... a west coast session of NCCN Academy for Excellence ... Business scheduled for July 9 - 10, 2009 in ... give pharmaceutical and biotech professionals the rare opportunity to ... operational issues from the provider and payer perspective. , ...
Cached Biology Technology:CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement 2CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement 3PDL BioPharma Provides Second Quarter 2009 Revenue Guidance of Approximately $125 Million 2PDL BioPharma Provides Second Quarter 2009 Revenue Guidance of Approximately $125 Million 3Industry Professionals Get Schooled in Real-World Oncology Issues at NCCN Academy 2Industry Professionals Get Schooled in Real-World Oncology Issues at NCCN Academy 3Industry Professionals Get Schooled in Real-World Oncology Issues at NCCN Academy 4
(Date:7/9/2015)... DUBLIN , July 07, 2015 ... has announced the addition of the "Biometrics ... and Forecasts 2015-2020" report to their offering. ... a major contributor to this growth and the ... US$5.5 billion in revenue for companies involved in ...
(Date:7/9/2015)... JOSE, Calif. , July 9, 2015 ... the leading developer of human interface solutions, ... technology, the industry,s first fully hardware encapsulated ... Match-in-Sensor secure authentication technology is literally off ... storage and biometric matching within the fingerprint ...
(Date:7/8/2015)... FRANKLIN LAKES , N.J. and NEW YORK ... and Company) and Guidepoint today announced ... selected start-up healthcare companies with free access to Guidepoint,s ... mentoring several start-ups that are developing cutting-edge technologies to ... of a dedicated Guidepoint research manager, each start-up entrepreneur ...
Breaking Biology News(10 mins):Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3
... study shows that the exposure to the controversial chemical Bisphenol ... tests. In the study, researchers compared BPA concentrations in mice ... the day, compared to the more common lab method of ... BPA in the blood of mice. This is the ...
... knows that newborns still have a lot of neurological work ... variety of nascent animals, genes provide them with only a ... nervous system to do its own finish work. Two studies ... for exposure to light in the environment as mouse pups ...
... New York June 5, 2011 Moisture and ... form a critical nexus between surface hydrology and atmospheric ... has suggested that soil moisture has had a positive ... observations of this. A team of researchers from Columbia ...
Cached Biology News:Exposure to BPA has been underestimated, new MU research says 2Early light refines the brain's circuitry for vision 2Early light refines the brain's circuitry for vision 3Early light refines the brain's circuitry for vision 4Columbia Engineering team makes major step in improving forecasts of weather extremes 2
Fast, sensitive quantitation of total MEK 1/2 concentration....
Argon Calibration Source...
RayBio Human Chemokine Antibody Array 1.1 (8) with Accessory, detects 38 chemokine factors (for lysate) Class: Antibody Array Products Product Group: Antibody Array...
Vybrant® Multidrug Resistance Assay Kit...
Biology Products: